The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. — Columbus, Ohio

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Clinical Trials Trust Score: 13/100 (FAILING). This profile has not yet been claimed by the site owner.

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has participated in 3 clinical trials.

Therapeutic areas: Triple Negative Breast Cancer, Metastatic Breast Cancer, Non-Hodgkin's Lymphoma.

Sponsors: Hoffmann-La Roche, Genentech, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Columbus

Browse all research sites in Ohio · View every site in Columbus

• Ohio State University Wexner Medical Center - Outpatient Care East
• Division of Radiation Oncology, The Ohio State University Wexner
• Mount Caramel East Hospital
• The Ohio State University Wexner Medical Center - Martha Morehouse Medical Pavilion
• The Wright Center of Innovation- The Ohio State University
• Ohio State University Wexner Medical Center: Division of Nephrology
• The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Solove Research Institute
• The University of Ohio
• University Hospital East Ohio State University Medical Center
• Division of Cardiology - The Ohio State University Medical Center
• Ohio State University Med Ctr; MS Center
• Ohio State University, Ohio State University Medical Center The Richard M Ross Heart Hospital

Sponsor Feasibility Report

Trust Score: 13/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc.?

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has a Crixeo Trust Score of 13/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. conducted?

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has 3 clinical trials on record. Their work covers Triple Negative Breast Cancer, Metastatic Breast Cancer, Non-Hodgkin's Lymphoma.

Is The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. accredited by Crixeo Clinical Trials?

The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Mark H. Zangmeister Ctr; Mid Ohio Onc/Hem Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.